首页 › 基金 › Yorkville Advisors Global, LP › NRSN
Yorkville Advisors Global, LP 对 NRSN 的持仓历史
NeuroSense Therapeutics Ltd · 医疗保健
Yorkville Advisors Global, LP 在 Q2 2026 的 13F 申报中披露持有 NRSN(NeuroSense Therapeutics Ltd)78,000 股,市值约 US$56K,约占其申报组合的 0.07%,在其申报持仓中市值排名第 34 位。 Yorkville Advisors Global, LP 最近 5 个申报季度中有 4 个季度披露了 NRSN 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Yorkville Advisors Global, LP 对 NRSN 的持仓演变
Yorkville Advisors Global, LP 于 Q2 2025 首次披露 NRSN 持仓:60,000 股(约 US$113K)。 在 4 次申报中,Yorkville Advisors Global, LP 0 次增持、1 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 78,000 股、市值约 US$56K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 60.00K | $113.40K | 新进 |
| Q4 2025 | 100.00K | $76.90K | 新进 |
| Q1 2026 | 78.00K | $58.89K | 减持 |
| Q2 2026 | 78.00K | $56.16K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NRSN 与 13F 数据
NRSN(NeuroSense Therapeutics Ltd)属于医疗保健行业。我们追踪的基金中还有 12 只申报持有 NRSN。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Yorkville Advisors Global, LP
常见问题
How long has Yorkville Advisors Global, LP held NRSN?
Yorkville Advisors Global, LP has disclosed NRSN holdings in 4 of the last 5 reported quarters, going back to Q2 2025.
What is Yorkville Advisors Global, LP's current position in NRSN?
As of Q2 2026, Yorkville Advisors Global, LP holds 78.00K shares of NRSN (NeuroSense Therapeutics Ltd), valued at $56.16K, representing 0.07% of its reported portfolio and ranking #34.
Has Yorkville Advisors Global, LP been buying or selling NRSN?
In the latest 13F filing (Q2 2026), Yorkville Advisors Global, LP held unchanged its position in NRSN.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.